Skip to main content
Tech.euFundingExplorerBeta

LoQus23 Therapeutics

LoQus23 is a DDF-formed company focussing on targeting DNA damage repair pathways to treat Huntington’s disease.

LoQus23 Therapeutics has raised €8.3M across 1 funding round from 2 investors, most recently a Seed round in Nov 2021. Based in London, UK; active in Healthtech. Data as of Nov 2026.

London, UK
Total raised
€8.3M
€8,315,020
Funding rounds
1
Investors
2
distinct backers
Active since
2021-11
latest 2021-11

Funding by year

EUR raised per year
LoQus23 Therapeutics — funding by year — interactive chart.
Data table
LoQus23 Therapeutics — funding by year
2021€8.3M

Signals

High confidence
Raise-next likelihood8
base rate 44% for Seed
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▼ Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Similar companies

same sector, similar size

Global coverage: FundingData